Population Pharmacokinetics of Clinafloxacin in Healthy Volunteers and Patients with InfectionsExperience with Heterogeneous Pharmacokinetic Data

被引：0
|
作者：
Bill Frame
Jeffrey Koup
Raymond Miller
Richard Lalonde
机构：
[1] PfizerGlobal Research and Development,Department of Clinical Pharmacokinetics and Pharmacodynamics
来源：
Clinical Pharmacokinetics | 2001年 / 40卷
关键词：
Mixed Effect Modelling; Interindividual Variability; Intraindividual Variability; Clinafloxacin; Combine Phase;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: Clinafloxacin is a new fluoroquinolone antibacterial with inhibitory activity against aerobic, anaerobic and atypical bacterial pathogens. The objectives of this study are to evaluate the pharmacokinetics of clinafloxacin in healthy volunteers and patients with infections and to describe our experience with mixed-effects modelling using heterogeneous pharmacokinetic data.
引用
收藏
页码：307 / 315
页数：8
相关论文
共 50 条
  • [31] A population pharmacokinetic study of tacrolimus in healthy Chinese volunteers and liver transplant patients
    Lu, Yan-xia
    Su, Qing-hong
    Wu, Ke-hua
    Ren, Yu-peng
    Li, Liang
    Zhou, Tian-yan
    Lu, Wei
    ACTA PHARMACOLOGICA SINICA, 2015, 36 (02) : 281 - 288
  • [32] Population pharmacokinetic analysis of sparsentan in healthy volunteers and patients with focal segmental glomerulosclerosis
    Wada, Russell
    Kleijn, Huub Jan
    Zhang, Lu
    Chen, Shang-Chiung
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2023, 12 (08): : 1080 - 1092
  • [33] Population Pharmacokinetic and Pharmacodynamic Modeling of Acetazolamide in Peritoneal Dialysis Patients and Healthy Volunteers
    Yue, Corinne Seng
    Huynh, Huu H.
    Raymond, Catherine
    Charbonneau, Louise
    Roy, Louise
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2013, 16 (01): : 89 - 98
  • [34] Population Pharmacokinetic/Pharmacodynamic Modeling of Clopidogrel in Korean Healthy Volunteers and Stroke Patients
    Lee, Joomi
    Hwang, Yangha
    Kang, Wonku
    Seong, Sook Jin
    Lim, Mi-sun
    Lee, Hae Won
    Yim, Dong-Seok
    Sohn, Dong Ryul
    Han, Seunghoon
    Yoon, Young-Ran
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (07): : 985 - 995
  • [35] A population pharmacokinetic model of cabozantinib in healthy volunteers and patients with various cancer types
    Steven Lacy
    Bei Yang
    Jace Nielsen
    Dale Miles
    Linh Nguyen
    Matt Hutmacher
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 1071 - 1082
  • [36] Evaluation of the Bioequivalence and Pharmacokinetics of Two Formulations of Gliclazide in Healthy Chinese Volunteers Using Population Pharmacokinetic Approach
    Huang, Ji-han
    Huang, Xiao-hui
    Li, Lu-jin
    Li, Yun-fei
    Wang, Kun
    Zheng, Qing-shan
    LATIN AMERICAN JOURNAL OF PHARMACY, 2013, 32 (04): : 490 - 497
  • [37] POPULATION PHARMACOKINETICS OF ORAL CEPHALOSPORINS IN CYSTIC FIBROSIS PATIENTS AND HEALTHY VOLUNTEERS.
    Sutaria, D.
    Jiao, Y.
    Tao, X.
    Stephan, U.
    Kinzig, M.
    Bulitta, J.
    Sorgel, F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S112 - S112
  • [38] Population Pharmacokinetics of Subcutaneous Pasireotide in Healthy Volunteers and Cushing’s Disease Patients
    Jerry Nedelman
    Roland Fisch
    Ke Hu
    Ines Paule
    Jocelyn Zhou
    Clinical Pharmacokinetics, 2018, 57 : 855 - 866
  • [39] Population Pharmacokinetics of Finafloxacin in Healthy Volunteers and Patients with Complicated Urinary Tract Infections
    Taubert, Max
    Lueckermann, Mark
    Vente, Andreas
    Dalhoff, Axel
    Fuhr, Uwe
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (04)
  • [40] Nonlinear Population Pharmacokinetics of Anifrolumab in Healthy Volunteers and Patients With Systemic Lupus Erythematosus
    Almquist, Joachim
    Kuruvilla, Denison
    Mai, Tu
    Tummala, Raj
    White, Wendy, I
    Tang, Weifeng
    Roskos, Lorin
    Chia, Yen Lin
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (09): : 1106 - 1120
12345